GURUFOCUS.COM » STOCK LIST » Consumer Defensive » Consumer Packaged Goods » HPC Biosciences Ltd (BOM:535217) » Definitions » EV-to-Revenue

HPC Biosciences (BOM:535217) EV-to-Revenue : 1,975.16 (As of May. 23, 2024)


View and export this data going back to 2013. Start your Free Trial

What is HPC Biosciences EV-to-Revenue?

EV-to-Revenue is calculated as enterprise value divided by its revenue. As of today, HPC Biosciences's enterprise value is ₹4,169.57 Mil. HPC Biosciences's Revenue for the trailing twelve months (TTM) ended in Mar. 2023 was ₹2.11 Mil. Therefore, HPC Biosciences's EV-to-Revenue for today is 1,975.16.

The historical rank and industry rank for HPC Biosciences's EV-to-Revenue or its related term are showing as below:

BOM:535217' s EV-to-Revenue Range Over the Past 10 Years
Min: 16.6   Med: 261.35   Max: 1978.48
Current: 1975.16

During the past 12 years, the highest EV-to-Revenue of HPC Biosciences was 1978.48. The lowest was 16.60. And the median was 261.35.

BOM:535217's EV-to-Revenue is not ranked
in the Consumer Packaged Goods industry.
Industry Median: 1.18 vs BOM:535217: 1975.16

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

As of today (2024-05-23), HPC Biosciences's stock price is ₹26.20. HPC Biosciences's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2023 was ₹0.01. Therefore, HPC Biosciences's PS Ratio for today is 2,015.38.


HPC Biosciences EV-to-Revenue Historical Data

The historical data trend for HPC Biosciences's EV-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

HPC Biosciences EV-to-Revenue Chart

HPC Biosciences Annual Data
Trend Mar14 Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23
EV-to-Revenue
Get a 7-Day Free Trial Premium Member Only Premium Member Only 313.51 345.00 181.04 867.04 1,978.48

HPC Biosciences Semi-Annual Data
Sep13 Mar14 Sep14 Mar15 Sep15 Mar16 Sep16 Mar17 Sep17 Mar18 Sep18 Mar19 Sep19 Mar20 Sep20 Mar21 Sep21 Mar22 Sep22 Mar23
EV-to-Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 181.04 - 867.04 - 1,978.48

Competitive Comparison of HPC Biosciences's EV-to-Revenue

For the Farm Products subindustry, HPC Biosciences's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


HPC Biosciences's EV-to-Revenue Distribution in the Consumer Packaged Goods Industry

For the Consumer Packaged Goods industry and Consumer Defensive sector, HPC Biosciences's EV-to-Revenue distribution charts can be found below:

* The bar in red indicates where HPC Biosciences's EV-to-Revenue falls into.



HPC Biosciences EV-to-Revenue Calculation

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

HPC Biosciences's EV-to-Revenue for today is calculated as:

EV-to-Revenue=Enterprise Value (Today)/Revenue (TTM)
=4169.572/2.111
=1,975.16

HPC Biosciences's current Enterprise Value is ₹4,169.57 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. HPC Biosciences's Revenue for the trailing twelve months (TTM) ended in Mar. 2023 was ₹2.11 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


HPC Biosciences  (BOM:535217) EV-to-Revenue Explanation

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

HPC Biosciences's PS Ratiofor today is calculated as:

PS Ratio=Share Price (Today)/Revenue per Share (TTM)
=26.20/0.013
=2,015.38

HPC Biosciences's share price for today is ₹26.20.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. {COMPANY->company}'s Revenue per Sharefor the trailing twelve months (TTM) ended in Mar. 2023 was ₹0.01.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


HPC Biosciences EV-to-Revenue Related Terms

Thank you for viewing the detailed overview of HPC Biosciences's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


HPC Biosciences (BOM:535217) Business Description

Traded in Other Exchanges
N/A
Address
Plot Number 22, Pooja Complex, Office Number 109, First Floor, Veer Savarkar Block, Shakarpur, Delhi, IND, 110092
HPC Biosciences Ltd is an Indian-based company that operates in the agricultural industry. The business activity of the group includes producing and marketing agricultural products, including wheat, rice, pulses, and vegetables. Geographically operations are performed through the regions of India, and it derives revenue from the sale of products.

HPC Biosciences (BOM:535217) Headlines

No Headlines